Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

The Use of Psychoactive Agents in Veterinary Medicine

Author(s):  Simpson Barbara S

Issue:  Mar/Apr 2001 - Compounding for Animals
View All Articles in Issue

Page(s):  86-88

The Use of Psychoactive Agents in Veterinary Medicine Page 1
The Use of Psychoactive Agents in Veterinary Medicine Page 2
The Use of Psychoactive Agents in Veterinary Medicine Page 3

Download in electronic PDF format for $75

Abstract:  Psychotropic drugs are used by veterinary behavior specialists and general veterinary practitioners to treat behavior problems of companion animals. Dogs, cats, pet birds, horses, and zoo animals benefit from this type of therapy. However, many drugs used to treat anxiety or depression in animals were designed for use in human patients. Compounding is a critical step in adapting those medications for use in different species. Formulations that improve palatability or facilitate administration can often determine the success or failure of therapy in veterinary patients, and compounding is often necessary to ensure accurate dosing when medications designed for adult humans are adapted for use in very small animals.

Related Keywords: animals, azaperones, benzodiazepines, birds, cats, dogs, MAOI, monoamine oxidase inhibitors, pet behavior, pets, phenothiazines, psychoactive agents, selective serotonin reuptake inhibitors, SSRI, TCA, tricyclic antidepressants, veterinary compounding, veterinary medicine, veterinary patients


Printer-Friendly Version

Related Articles from IJPC
(Click for Abstract / Details / Purchase)
The Use of Psychoactive Agents in Veterinary Medicine
Simpson Barbara S
Mar/Apr 2001
Pg. 86-88

Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Compounding for Behavior Problems in Animals
Vail Jane
, Davidson Gigi S
May/Jun 2005
Pg. 185-192

Palliative Care and Compounding for Household Pets
Gaskins Jessica L
Nov/Dec 2012
Pg. 452-455

Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report
Pope George
, Daleo Charles, Batson SL
Sep/Oct 2019
Pg. 358-364

Compounding for the Treatment of COVID-19 and Long COVID, Part 5: Associated Conditions, Prophylaxis, and Effective Treatment
Riepl Mike
, Kaiser Joe
Sep/Oct 2023
Pg. 368-380

Imatinib 40-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2016
Pg. 510

Compounding for Cancer in Companion Animals
Mixon William
, Northrup Nicole, Vail Jane
Jan/Feb 2009
Pg. 42-49

Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease
Corsini Lindsay
, Williams LaVonn A
Mar/Apr 2011
Pg. 124-128

Providing Positive Outcomes through Compounding for Animal Cancer Patients
Davidson Gigi S
Jul/Aug 2000
Pg. 264-272

Compounding for the Effects of Weapons of Mass Destruction
Sammarco Domenic A
Jan/Feb 2003
Pg. 10-15

View Sample
Navigating New Territories in Compounding for Veterinary Medicine
Davidson Gigi S
Sep/Oct 2002
Pg. 324-327

Veterinary Compounding: A Bird's Eye View
Jordan Dinah G
Jul/Aug 1997
Pg. 222-227

Including Pets in Diabetic Care
Davidson Gigi S
Mar/Apr 2007
Pg. 126-130

Evaluating Transdermal Medication Forms for Veterinary Patients, Part 1
Davidson Gigi S
Mar/Apr 2001
Pg. 95-96

Evaluating Transdermals Medication Froms for Veterinary Patients, Part 2
Davidson Gigi S
May/Jun 2001
Pg. 214-215

Compounding Prokinetic Medications for Companion Animals
Gaskins Jessica
Jul/Aug 2012
Pg. 276-286

Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Chuong Monica
, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
Nov/Dec 2019
Pg. 504-510

Basics: Excipients Used in Nonsterile Compounding, Part 6: Compounding with Viscosity-increasing Agents
Allen Loyd V Jr
May/Jun 2020
Pg. 206-212

Return to Top